Source briefingSeptember 11, 2026Human Rights

Pakistan: Anti-Terrorism Bill Threatens Fair Trials

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.

What the source reports

Click to expand Image The Supreme Court of Pakistan in Islamabad, Pakistan, June 20, 2022.  © 2022 Anjum Naveed/AP Photo (New York) – The Punjab provincial assembly in Pakistan on August 31, 2026, passed a bill that would threaten the right to a fair trial in counterterrorism proceedings, Human Rights Watch said today.

The provincial governor should return the bill to the assembly, which should develop rights-respecting protections for such proceedings, subject to independent oversight.The Anti-Terrorism (Punjab Amendment) Bill 2026 authorizes unspecified government officials…

Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.

Source & verification

Primary source: Human Rights Watch News · September 11, 2026

Read the original source

FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.

Continue reading

EMA/PE/0000181364

What is established The European Medicines Agency (EMA) has granted a decision regarding a paediatric investigation plan (PIP) for vosoritide as of 8 August…

EMA/PE/0000228795

Evidence Dossier: EMA Paediatric Investigation Plan for Ambrisentan/Tadalafil What is established The European Medicines Agency (EMA) has officially adopted a paediatric investigation plan (PIP)…

EMA/PE/0000261344

Evidence Dossier: EMA Decision on Colchicine Paediatric Investigation Plan (PIP) What is established On 8 August 2025, the European Medicines Agency (EMA) granted a…